Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
United States (Primary) | PRIMARYUSA | Univ | 6,210 | 64,411,905 | 0.08% | -0.65% | 0.76% | 4.05% | -0.26% | 11.14% |
Healthcare | HEALTHCARE | Sector | 1,189 | 5,986,722 | -0.06% | -1.92% | -0.73% | -8.35% | -4.60% | -6.07% |
Biopharmaceuticals | BIOPHARMA | SubSec | 617 | 2,860,923 | -0.14% | -2.35% | 1.53% | -9.01% | -2.71% | -8.63% |
System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 291 | 1,217,473 | -0.15% | -2.43% | 2.31% | -9.69% | -2.76% | -9.57% |
Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 94 | 89,020 | 0.82% | -4.77% | -2.46% | -11.93% | -16.12% | -19.32% |
Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
SAGE Therapeutics, Inc. | SAGE:USASAGE:USA | Stock | 1 | 571 | 0.11% | 34.86% | 29.14% | 13.98% | 70.81% | -18.99% |
Scholar Rock Holding Corp. | SRRK:USASRRK:USA | Stock | 1 | 3,446 | 16.60% | 10.03% | 20.42% | 7.97% | -15.28% | 313.67% |
Stoke Therapeutics, Inc. | STOK:USASTOK:USA | Stock | 1 | 632 | -0.77% | 0.61% | 17.70% | 38.90% | -5.47% | -25.83% |
Capricor Therapeutics, Inc. | CAPR:USACAPR:USA | Stock | 1 | 545 | -2.05% | -9.13% | 15.14% | -16.85% | -13.98% | 140.73% |
Praxis Precision Medicines, Inc. | PRAX:USAPRAX:USA | Stock | 1 | 874 | -1.13% | -3.64% | 15.05% | 14.01% | -40.63% | 17.56% |
PTC Therapeutics, Inc. | PTCT:USAPTCT:USA | Stock | 1 | 3,995 | -0.83% | -0.77% | 7.39% | -10.95% | 3.74% | 42.46% |
Anavex Life Sciences Corp. | AVXL:USAAVXL:USA | Stock | 1 | 771 | 1.23% | 10.12% | 6.99% | -9.06% | -1.63% | 142.09% |
ACADIA Pharmaceuticals, Inc. | ACAD:USAACAD:USA | Stock | 1 | 3,835 | 0.66% | 2.91% | 4.37% | 33.59% | 32.35% | 54.65% |
Neurocrine Biosciences, Inc. | NBIX:USANBIX:USA | Stock | 1 | 12,604 | 1.95% | 2.53% | 3.66% | 15.66% | -4.31% | -5.90% |
Xenon Pharmaceuticals, Inc. | XENE:USAXENE:USA | Stock | 1 | 2,443 | 0.63% | -1.12% | 3.07% | -8.46% | -22.78% | -12.84% |
Denali Therapeutics, Inc. | DNLI:USADNLI:USA | Stock | 1 | 2,047 | 0.57% | -7.24% | 1.29% | -3.56% | -39.50% | -31.20% |
GH Research PLC | GHRS:USAGHRS:USA | Stock | 1 | 734 | -1.25% | -14.14% | 1.20% | -1.91% | 44.39% | -4.52% |
Mind Medicine (MindMed), Inc. | MNMD:USAMNMD:USA | Stock | 1 | 535 | 5.66% | -4.19% | 1.14% | 6.62% | -4.19% | -5.21% |
S&P 500 | SPY:USASPY:USA | Benchmark | 14,318 | 86,187,913 | -0.02% | -0.65% | 0.44% | 5.97% | -0.91% | 10.59% |
Supernus Pharmaceuticals, Inc. | SUPN:USASUPN:USA | Stock | 1 | 1,845 | 1.96% | -0.57% | -0.27% | 1.98% | -9.67% | 26.82% |
Jazz Pharmaceuticals Plc | JAZZ:USAJAZZ:USA | Stock | 1 | 6,670 | 1.11% | -2.05% | -1.40% | -23.00% | -13.55% | -5.49% |
Edgewise Therapeutics, Inc. | EWTX:USAEWTX:USA | Stock | 1 | 1,378 | -0.14% | -8.13% | -2.16% | -39.25% | -55.74% | -16.70% |
Biogen, Inc. | BIIB:USABIIB:USA | Stock | 1 | 18,538 | -0.02% | -4.90% | -2.24% | -10.50% | -15.91% | -44.12% |
Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 94 | 89,020 | 0.82% | -4.77% | -2.46% | -11.93% | -16.12% | -19.32% |
Axsome Therapeutics, Inc. | AXSM:USAAXSM:USA | Stock | 1 | 5,064 | 1.27% | -4.80% | -5.00% | -18.52% | 14.73% | 35.38% |
Alkermes Plc | ALKS:USAALKS:USA | Stock | 1 | 4,835 | -1.48% | -5.99% | -6.74% | -13.53% | -4.37% | 17.27% |
Catalyst Pharmaceuticals, Inc. | CPRX:USACPRX:USA | Stock | 1 | 2,782 | -1.77% | -10.23% | -7.39% | -1.51% | 5.36% | 52.07% |
Dyne Therapeutics, Inc. | DYN:USADYN:USA | Stock | 1 | 1,225 | -0.74% | -26.01% | -7.55% | -12.07% | -58.70% | -66.09% |
Taysha Gene Therapies, Inc. | TSHA:USATSHA:USA | Stock | 1 | 527 | 0.78% | -3.75% | -7.89% | 51.18% | 27.86% | -36.23% |
Biohaven Ltd. | BHVN:USABHVN:USA | Stock | 1 | 1,469 | -1.17% | -8.29% | -8.63% | -48.94% | -65.28% | -56.38% |
Dianthus Therapeutics, Inc. | DNTH:USADNTH:USA | Stock | 1 | 560 | 0.98% | -3.75% | -9.50% | -14.68% | -27.42% | -30.96% |
Harmony Biosciences Holdings, Inc. | HRMY:USAHRMY:USA | Stock | 1 | 1,864 | 0.03% | -7.57% | -9.55% | -6.93% | -1.75% | 10.59% |
Sarepta Therapeutics, Inc. | SRPT:USASRPT:USA | Stock | 1 | 2,041 | -3.66% | -45.07% | -45.26% | -71.72% | -83.62% | -82.22% |
* Colors indicate performance relative to the benchmark.